Company intelligence / Profile preview

Costa Brava Partnership III

Boston, Massachusetts, United States

Ownership: Private
Development stage: Other

Overview

Costa Brava Partnership III is an investment vehicle and hedge fund managed by Costa Brava Strategies. While not a biotechnology company itself, the partnership is heavily involved in the life sciences sector as a significant institutional investor and activist shareholder. The firm frequently takes positions in clinical-stage pharmaceutical and medical device companies, often engaging in corporate governance and strategic oversight to maximize shareholder value. Its portfolio has historically included notable holdings in companies such as Natus Medical and various oncology-focused biotech firms.

Industry: Investors

Beyond the preview

Go deeper on Costa Brava Partnership III.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Costa Brava Partnership III.

Explore the full profile